J&J starts clinical trial of Ebola vaccine in Sierra Leone

Oct 9 (Reuters) - Johnson & Johnson said it has begun a safety and immunogenicity clinical trial of a preventive Ebola vaccine regimen in Sierra Leone.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.